Gilead Sciences and the U.S. Attorney's Office for the Southern District of New York reached a $202 million settlement over allegations that the company used its speaker programs to pay kickbacks to physicians to induce them to prescribe Gilead’s products. The settlement resolves claims that the company offered and paid kickbacks in the form of honoraria payments, meals and t... Read More